A novel approach to improve cardiac performance: cardiac myosin activators

por Teerlink, John R.
Publicado 2009

Systolic time intervals in patients with heart failure: time to teach new dogs old tricks

por Njoroge, Joyce N., Teerlink, John R.
Publicado 2020

Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure

por Njoroge, Joyce N., Teerlink, John R.
Publicado 2021

Acute Decompensated Heart Failure Update

por Teerlink, John R, Alburikan, Khalid, Metra, Marco, Rodgers, Jo E
Publicado 2015

Relaxin: Review of Biology and Potential Role in Treating Heart Failure

por Teichman, Sam L., Unemori, Elaine, Teerlink, John R., Cotter, Gad, Metra, Marco
Publicado 2010

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond

por Teerlink, John R., Metra, Marco, Zacà, Valerio, Sabbah, Hani N., Cotter, Gadi, Gheorghiade, Mihai, Cas, Livio Dei
Publicado 2009

Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication

por Lewis, Roger J, Connor, Jason T, Teerlink, John R, Murphy, James R, Cooper, Leslie T, Hiatt, William R, Brass, Eric P
Publicado 2011

Vasodilators in the treatment of acute heart failure: what we know, what we don’t

por Metra, Marco, Teerlink, John R., Voors, Adriaan A., Felker, G. Michael, Milo-Cotter, Olga, Weatherley, Beth, Dittrich, Howard, Cotter, Gad
Publicado 2008

Relaxin, a pleiotropic vasodilator for the treatment of heart failure

por Teichman, Sam L., Unemori, Elaine, Dschietzig, Thomas, Conrad, Kirk, Voors, Adriaan A., Teerlink, John R., Felker, G. Michael, Metra, Marco, Cotter, Gad
Publicado 2008

Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program

por Wiklund, Ingela, Anatchkova, Milena, Oko-Osi, Hafiz, von Maltzahn, Robyn, Chau, Dina, Malik, Fady I., Patrick, Donald L., Spertus, John, Teerlink, John R.
Publicado 2016

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study

por Metra, Marco, Teerlink, John R., Felker, G. Michael, Greenberg, Barry H., Filippatos, Gerasimos, Ponikowski, Piotr, Teichman, Sam L., Unemori, Elaine, Voors, Adriaan A., Weatherley, Beth Davison, Cotter, Gad
Publicado 2010

Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study

por Felker, G. Michael, Solomon, Scott D., McMurray, John J.V., Cleland, John G.F., Abbasi, Siddique A., Malik, Fady I., Zhang, Hanze, Globe, Gary, Teerlink, John R.
Publicado 2020

Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials

por Ahmad, Tariq, Miller, P. Elliott, McCullough, Megan, Desai, Nihar R., Riello, Ralph, Psotka, Mitchell, Böhm, Michael, Allen, Larry A., Teerlink, John R., Rosano, Giuseppe M.C., Lindenfeld, Joann
Publicado 2019

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF

por Metra, Marco, Ponikowski, Piotr, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Filippatos, Gerasimos, Greenberg, Barry H., Hua, Tsushung A., Severin, Thomas, Unemori, Elaine, Voors, Adriaan A., Teerlink, John R.
Publicado 2013

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial

por Vardeny, Orly, Claggett, Brian, Packer, Milton, Zile, Michael R., Rouleau, Jean, Swedberg, Karl, Teerlink, John R., Desai, Akshay S., Lefkowitz, Martin, Shi, Victor, McMurray, John J.V., Solomon, Scott D.
Publicado 2016

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial

por Filippatos, Gerasimos, Teerlink, John R., Farmakis, Dimitrios, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Greenberg, Barry H., Hua, Tsushung, Ponikowski, Piotr, Severin, Thomas, Unemori, Elaine, Voors, Adriaan A., Metra, Marco
Publicado 2014

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF

por Voors, Adriaan A, Davison, Beth A, Teerlink, John R, Felker, G Michael, Cotter, Gad, Filippatos, Gerasimos, Greenberg, Barry H, Pang, Peter S, Levin, Bruce, Hua, Tsushung A, Severin, Thomas, Ponikowski, Piotr, Metra, Marco
Publicado 2014

Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study

por Meyer, Sven, Teerlink, John R., Metra, Marco, Ponikowski, Piotr, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Filippatos, Gerasimos, Greenberg, Barry H., Hua, Tsushung A., Severin, Thomas, Qian, Min, Voors, Adriaan A.
Publicado 2016

Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial

por Biegus, Jan, Demissei, Biniyam, Postmus, Douwe, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Filippatos, Gerasimos, Gimpelewicz, Claudio, Greenberg, Barry, Metra, Marco, Severin, Thomas, Teerlink, John R., Voors, Adriaan A., Ponikowski, Piotr
Publicado 2019

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials

por Grand, Johannes, Miger, Kristina, Sajadieh, Ahmad, Køber, Lars, Torp‐Pedersen, Christian, Ertl, Georg, López‐Sendón, José, Pietro Maggioni, Aldo, Teerlink, John R., Sato, Naoki, Gimpelewicz, Claudio, Metra, Marco, Holbro, Thomas, Nielsen, Olav W.
Publicado 2021